sulfamethoxypyridazine has been researched along with Granulocytic Leukemia, Chronic in 1 studies
Sulfamethoxypyridazine: A sulfanilamide antibacterial agent.
sulfamethoxypyridazine : A sulfonamide consisting of pyridazine having a methoxy substituent at the 6-position and a 4-aminobenzenesulfonamido group at the 3-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Melo, ACC | 1 |
| Santana, JMSVP | 1 |
| Nunes, KJRC | 1 |
| Rodrigues, BL | 1 |
| Castilho, N | 1 |
| Gabriel, P | 1 |
| Moraes, AH | 1 |
| Marques, MA | 1 |
| de Oliveira, GAP | 1 |
| de Souza, ÍP | 1 |
| Terenzi, H | 1 |
| Pereira-Maia, EC | 1 |
1 other study available for sulfamethoxypyridazine and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
New Heteroleptic Ruthenium(II) Complexes with Sulfamethoxypyridazine and Diimines as Potential Antitumor Agents.
Topics: Antineoplastic Agents; Circular Dichroism; Humans; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-A | 2019 |